Fundraising Fox

Trice Medical

Malvern, US · Founded 2011 · Delaware corporation · 53 employees on LinkedIn · 3 known investors

Trice Medical develops minimally invasive medical devices, including ultrasonic tenotomy systems for percutaneous tissue removal (treating tendinopathy, calcific tendonitis, and bone spurs), endoscopic carpal tunnel and ligament release systems, diabetic foot ulcer procedure tools, and portable high-resolution arthroscopy. The products are intended for use by clinicians performing minimally invasive orthopedic and wound-care procedures.

BiotechHealthtechMedical Devices

Founders & leadership

Trice Medical was founded in 2011 by Jeffrey O'Donnell.

JO
Jeffrey O'DonnellFounder
MFMark Foster
Mark FosterinPresident and Chief Executive Officer2019–2023
RKRichard Kienzle
Richard KienzleinExecutive

Board

AD
Alan DavisBoard director
RS
Randy ScottBoard director
GK
Gary KurtzmanBoard director
MS
Michael SchraubenBoard director
PK
Puneet KhannaBoard director
VP
Vasant PadmanabhanBoard director
SA
Steve AlmanyBoard director

Investors · 3

BioStar VenturesreportedPetoskey
HealthQuest CapitalreportedRedwood City

Also in the syndicate · 1

Bioventus Inc.lead

Reported raises · per SEC filings

Form D private placements

$123.2M disclosed across 9 rounds · 2012–2023

▶$10.5MraisedAug 2023 · 2 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • NIMESH SHAHDirector
  • CHAD NORMANDirector
  • MICHAEL STEENExecutive Officer, Director
Offering amount
$17.5M
Amount sold
$10.5M
First sale
Jul 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$7.3MraisedOct 2022 · 209 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • ALAN DAVISDirector
  • ERIC C. SALZMANDirector
  • MICHAEL SCHRAUBENDirector
  • MARK FOSTERExecutive Officer, Director
  • VASANT PADMANABHANDirector
  • CHRIS YAMAMOTODirector
  • RANDY SCOTTDirector
Offering amount
$7.3M
Amount sold
$7.3M
First sale
Oct 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$27.6MraisedSep 2021 · 39 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael SchraubenDirector
  • Randy ScottDirector
  • Mark FosterExecutive Officer, Director
  • Alan DavisDirector
  • Gary KurtzmanDirector
  • Vasant PadmanabhanDirector
  • Chris YamamotoDirector
Offering amount
$37.6M
Amount sold
$27.6M
First sale
Aug 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$10.2MraisedApr 2021 · 22 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Alan DavisDirector
  • Randy ScottDirector
  • Mark FosterExecutive Officer, Director
  • Vasant PadmanabhanDirector
  • Gary KurtzmanDirector
  • Michael SchraubenDirector
Offering amount
$11M
Amount sold
$10.2M
Minimum investment
$1
Proceeds to insiders
$500K
First sale
Mar 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.1MraisedMar 2020 · 8 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Alan DavisDirector
  • Randy ScottDirector
  • Vasant PadmanabhanDirector
  • Michael SchraubenDirector
  • Craig K. CarraExecutive Officer
  • Gary KurtzmanDirector
  • Mark FosterExecutive Officer, Director
Offering amount
$6M
Amount sold
$2.1M
Minimum investment
$1
Proceeds to insiders
$700K
First sale
Mar 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$40.6MraisedJan 2019 · 47 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • William A. HawkinsDirector
  • Randy ScottDirector
  • Mark FosterExecutive Officer
  • Vasant PadmanabhanDirector
  • Gary KurtzmanDirector
  • Mark SchraubonDirector
  • Alan DavisDirector
  • Jeffrey F. O'Donnell, Sr.Executive Officer, Director
  • Craig CarraExecutive Officer
Offering amount
$42.3M
Amount sold
$40.6M
Minimum investment
$1
Finders' fees
$250K
First sale
May 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5MraisedDec 2016 · 5 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Richard WashburnExecutive Officer
  • Gary KurtzmanDirector
  • Craig CarraExecutive Officer
  • William A. HawkinsDirector
  • Steve AlmanyDirector
  • Garheng KongDirector
  • Jeffrey F. O'DonnellExecutive Officer, Director
  • Mark FosterExecutive Officer
Offering amount
$6.3M
Amount sold
$5M
First sale
Dec 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$18.1MraisedJan 2015 · 30 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Richard KienzleDirector
  • Richard WashburnExecutive Officer
  • Garheng KongDirector
  • Jeffrey O'DonnellExecutive Officer, Director
  • Craig CarraExecutive Officer
  • Steve AlmanyDirector
  • Gary KurtzmanDirector
Offering amount
$18.1M
Amount sold
$18.1M
First sale
Jul 2014
Incorporated
Corporation, Delaware, 2011
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap
Cirtec Medical, LLC13 shared keywordsCirtec Medical is a design-to-market partner that helps medical device innovators develop, prototype, and commercialize complex Class II and III medical devices. The company offers vertically integrated, end-to-end capabilities spanning engineering, advanced manufacturing, and program management for active implantable systems, interventional devices, and precision medical technologies.

Companies competing with Trice Medical for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Trice Medical Receives Investment and International Distribution Partnership from Bioventus, Inc. - Trice Medicaltricemedical.com · Aug 2021Trice Medical raises more than $10M - MassDevicemassdevice.com · Apr 2021Trice Medical Closes $19.3 Million Series C Financing To Address Increased Demand For Mi-Eyeprnewswire.com · Jun 2017Trice Medical Raised Additional $6.5M; Closes $18.1M Series B Round - FinSMEsfinsmes.com · Feb 2015Trice Medical Raises Unexpected Additional Series B Funding - ODTodtmag.com · Feb 2015Trice Medical Raises $11.6 Million Series B Financing Led by Safeguard Scientifics; Appoints Jeffrey O'Donnell Sr. to Chairman and CEOprweb.com · Jul 2014

Frequently asked questions

What does Trice Medical do?
Trice Medical develops minimally invasive medical devices, including ultrasonic tenotomy systems for percutaneous tissue removal (treating tendinopathy, calcific tendonitis, and bone spurs), endoscopic carpal tunnel and ligament release systems, diabetic foot ulcer procedure tools, and portable high-resolution arthroscopy. The products are intended for use by clinicians performing minimally invasive orthopedic and wound-care procedures.
Who founded Trice Medical?
Trice Medical was founded by Jeffrey O'Donnell in 2011.
Who are Trice Medical's investors?
Trice Medical's investors include BioStar Ventures, HealthQuest Capital.
How much funding has Trice Medical raised?
Trice Medical has disclosed $123.2M raised across 9 rounds.
Where is Trice Medical headquartered?
Trice Medical is headquartered in Malvern, US.